Sale Of Non-Strategic Assets

12 Months Ended

Sep. 30, 2011

Sale Of Non-Strategic Assets

Sale Of Non-Strategic Assets

NOTE 3. SALE OF NON-STRATEGIC ASSETS

In June 2009, we completed the sale of patents and intellectual property related to our Negative Pressure Wound Therapy technology for which there were no capitalized costs reflected on our consolidated balance sheet.  In May 2009, we finalized a strategic development agreement with Teletracking Technologies, Inc. ("TeleTracking") that resulted in the purchase by TeleTracking of certain assets and obligations related to the NaviCare® Patient Flow product line.  These combined transactions resulted in a gain of $10.2 million, net of related transaction costs.